Diphtheria News and Research

RSS
Diphtheria is a disease caused by a bacterium, Corynebacterium diphtheriae, that usually affects the tonsils, throat, nose and/or skin. It is passed from person to person by droplet transmission, usually by breathing in diphtheria bacteria after an infected person has coughed or sneezed. Although diphtheria disease is rare in the U.S., it appears that C diphtheriae continues to circulate in areas of the country with previously endemic diphtheria. Diphtheria also occurs in many other parts of the world.
Walls Street journal examines big pharma's 'growing interest' in emerging-market vaccine development, production

Walls Street journal examines big pharma's 'growing interest' in emerging-market vaccine development, production

WHO, UNICEF launch 6-year $39B plan to prevent, treat pneumonia; World Pneumonia Day coverage

WHO, UNICEF launch 6-year $39B plan to prevent, treat pneumonia; World Pneumonia Day coverage

Sanofi Pasteur presents Menactra vaccine safety data at the IDSA

Sanofi Pasteur presents Menactra vaccine safety data at the IDSA

Study indicates possibility of a vaccine to prevent Group B Streptococcus infection

Study indicates possibility of a vaccine to prevent Group B Streptococcus infection

sanofi-aventis reports financial results for the third quarter of 2009

sanofi-aventis reports financial results for the third quarter of 2009

Vaccination rates need improvement; racial and ethnic disparities in vaccination coverage

Vaccination rates need improvement; racial and ethnic disparities in vaccination coverage

News outlets examine challenges with expanding global child immunization campaigns

News outlets examine challenges with expanding global child immunization campaigns

More infants are being immunized but funding gap leaves millions of children still at risk

More infants are being immunized but funding gap leaves millions of children still at risk

Phase 1 clinical trial to test safety and activity of human MAB launched in India

Phase 1 clinical trial to test safety and activity of human MAB launched in India

British Prime Minister to unveil $1b effort to improve health systems in developing countries

British Prime Minister to unveil $1b effort to improve health systems in developing countries

Exhibition on history of immunology to be presented at 2nd European Congress of Immunology

Exhibition on history of immunology to be presented at 2nd European Congress of Immunology

COPD patients to have better protection against pneumonia with new vaccine

COPD patients to have better protection against pneumonia with new vaccine

Nanoparticle-delivered suicide gene therapy effectively reduces ovarian tumor burden in mice

Nanoparticle-delivered suicide gene therapy effectively reduces ovarian tumor burden in mice

CDC recommends routine health examintion for all school-age children

CDC recommends routine health examintion for all school-age children

FDA issues marketing approval for APP Pharmaceuticals' Penicillin G potassium for Injection, USP

FDA issues marketing approval for APP Pharmaceuticals' Penicillin G potassium for Injection, USP

The Gambia introduces pneumococcal immunisation programme

The Gambia introduces pneumococcal immunisation programme

Parents need immunizations too!

Parents need immunizations too!

Phase 1 clinical trial starts for new antibody aimed at hepatitis C virus

Phase 1 clinical trial starts for new antibody aimed at hepatitis C virus

New nano-gene therapy technique could fight late-stage tumors

New nano-gene therapy technique could fight late-stage tumors

Nanoparticles show potential as part of new therapy for advanced ovarian cancer

Nanoparticles show potential as part of new therapy for advanced ovarian cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.